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Edited by Varda RotterAbstract RPA is an important component of DNA replication,
repair and recombination, but its involvement in the signaling of
cell-cycle checkpoints is not well understood. In this study, we
show that knockdown of RPA1 by siRNA duplexes induces
ATM (Ser1981) and Chk2 (Thr68), but not Chk1 (Ser345) phos-
phorylation and results in p21 upregulation in HeLa cells. How-
ever, the induction of Chk2 (Thr68) phosphorylation and p21
expression by RPA1 siRNA transfection can be completely
blocked by the ATM inhibitor caﬀeine. Moreover, transfection
of siRNAs targeting ATM dramatically reduces Chk2 (Thr68)
phosphorylation in RPA1 knockdown cells. Taken together,
these results suggest that loss of RPA1 activates the Chk2 sig-
naling pathway in an ATM-dependent manner.
 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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checkpoint1. Introduction
Cell-cycle checkpoints are evolutionarily conserved surveil-
lance mechanisms that play essential roles in the maintenance
of genomic stability and accurate transmission of the genome
to the next generation [1]. In response to DNA damage or rep-
lication inhibition, cells activate a set of signaling pathways to
slow genome duplication and segregation in order to gain extra
time for the damage to be repaired or elimination of unrepair-
able cells by apoptosis [2]. Among the central components of
the cell-cycle checkpoint machinery are the phosphatidylinosi-
tol 3-kinase (PI3K)-related kinases Rad3/Mec1 in yeast, and
ATM and ATR in metazoans [3]. It is believed that ATM pri-
marily responds to double-stranded DNA breaks, whereas
ATR is required for response to numerous chemical and phys-
ical DNA-damaging agents that interfere with DNA replica-
tion [3]. These proteins appear to act as ‘‘transducer kinases’’
that recognize a DNA damage signal and transmit it to the
downstream ‘‘eﬀector kinases’’ Chk1 and Chk2, which in turn
phosphorylate a variety of key substrates, such as Cdc25 and
p53, in order to coordinate cell-cycle progression, DNA repair
and apoptosis [3,4]. In addition to the PI3K-related kinases,
the Rad family proteins (Rad1, Rad9, Hus1 and Rad17) are
suggested to function as DNA damage ‘‘sensors’’ that facilitate*Corresponding author. Fax: +1 813 979 7265.
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However, genetic studies also indicate that Rad3/Mec1/ATR
and the Rad9–Hus1–Rad1 complex are recruited indepen-
dently to sites of DNA damage [5–7].
RPA is a heterotrimeric single-stranded DNA (ssDNA)-
binding protein complex composed of three subunits of p70
(RPA1), p34 (RPA2) and p14 (RPA3), and plays an essential
role in DNA replication, repair and recombination [8,9]. The
p34 subunit becomes hyperphosphorylated in cells after expo-
sure to various genotoxic agents, suggesting that RPA2 phos-
phorylation is probably important for the cellular response to
DNA damage [10,11]. The kinases implicated in this response
are DNA-PK and ATM [12,13]. Both DNA-PK and ATM
interact with RPA, and DNA damage-induced RPA2 phos-
phorylation disrupts RPA association with these proteins
[14,15]. Moreover, it has recently been shown that RPA is re-
quired for the recruitment of ATR, ATRIP and Rad17 to sites
of DNA damage [16–18], implying its involvement in DNA
damage checkpoints. In this report, we demonstrate that while
Rad9 is not essential for VP-16-induced Chk2 phosphoryla-
tion, loss of RPA1 activates Chk2 through an ATM-dependent
pathway.2. Materials and methods
2.1. siRNA duplexes
The 21-nucleotide siRNA duplexes were synthesized and puriﬁed by
Dharmacon Research (Boulder, CO). The siRNA sequences targeting
human Rad9 (GenBank Accession No. U53174) and GFP (Gen-
Bank Accession No. U57606) were described previously [19]. The se-
quence of siRNA targeting human RPA1 (GenBank Accession No.
NM 002945) was 5 0-AAGCACUAUCAUUGCGAAUCC-30. The
siRNA SMARTpool targeting human ATM was purchased from
Dharmacon Research (Boulder, CO).
2.2. Transfection of mammalian cells with siRNA duplexes
Transfection of siRNA duplexes was performed as previously de-
scribed [19]. Brieﬂy, 6 ll of oligofectamine reagent was mixed with
24 ll of Opti-MEM (Invitrogen) at room temperature for 7–10 min
and then incubated with a mixture of 6 ll of 20 lM siRNA duplex
and 100 ll of Opti-MEM for an additional 20–25 min at room temper-
ature. After 64 ll of fresh Opti-MEM was added, 200 ll of siRNA–oli-
gofectamine complexes was applied to each well of a 12-well plate of
cultured cells with 0.8 ml of Opti-MEM.2.3. Immunoblotting
Cell lysates were prepared in an appropriate volume of 1% Triton X-
100 lysis buﬀer (10 mMHEPES, pH 7.5, 150 mMNaCl, 5 mM EDTA,
10% glycerol and 1% Triton X-100) with protease and phosphatase
inhibitors. For detecting phospho-Chk2, cell lysates were prepared
with SDS-sampling buﬀer (62.5 mM Tris–HCl, pH 8.0, 2% SDS andblished by Elsevier B.V. All rights reserved.
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transferred to polyvinylidene diﬂuoride membrane (Bio-Rad Labora-
tories), probed with the indicated antibodies and detected with en-
hanced chemiluminescence (Amersham). The anti-Rad9 polyclonal
antiserum was produced in rabbits using puriﬁed recombinant GST-
tagged human Rad9 protein. The anti-RPA1 monoclonal antibody,
anti-RPA2 monoclonal antibody and anti-ATM polyclonal antibody
were purchased from Oncogene. The anti-phospho-Chk1 (Ser345)
and anti-phospho-Chk2 (Thr68) polyclonal antibodies were from Cell
Signaling. The anti-phospho-ATM (Ser1981) polyclonal antibody was
purchased from Rockland Immunochemicals. The anti-p21 polyclonal
antibody and anti-tubulin monoclonal antibody were from Santa Cruz
and Sigma, respectively.3. Results and discussion
3.1. Knockdown of RPA1 induces Chk2 (Thr68)
phosphorylation
To determine the importance of RPA on DNA damage re-
sponse of mammalian cells, we performed RNA interference
experiments in HeLa cells. It is known that VP-16 treatment
induces Chk2 phosphorylation at the Thr68 residue [20], which
is required for the catalytic activity of this checkpoint kinase
[21]. Therefore, we examined the role of Rad9 and RPA1 on
VP-16-induced Chk2 (Thr68) phosphorylation in HeLa cells
transfected with siRNAs speciﬁc for Rad9 (siRad9) and
RPA1 (siRPA1). Immunoblot analysis of Chk2 with an anti-
body speciﬁc for the phosphorylated Thr68 residue revealed
that VP-16 treatment induced Chk2 phosphorylation at
Thr68 in control GFP siRNA (siGFP)-transfected cells (Fig.
1). Knockdown of Rad9 had little to no eﬀect on Thr68 phos-
phorylation in cells with or without DNA damage (Fig. 1). InFig. 1. Knockdown of RPA1 induces Chk2 (Thr68) phosphorylation. (A) H
siRPA1 duplexes three times over a 3-day period. Seventy-two hours after th
DMSO control () for 24 h. Cell lysates were prepared with SDS-samplin
indicated antibodies. The immunoblotting results in (B) were quantitated
relative to those of untreated siGFP cells, which were set as 1.0, are showncontrast, VP-16-induced Chk1 (Ser345) phosphorylation was
attenuated in cells transfected with siRad9 or siRPA1 com-
pared to control siGFP (Fig. 1A). These observations are con-
sistent with the Rad9 checkpoint complex being important for
Chk1 but dispensable for Chk2 activation induced by DNA
damage [22,23]. However, transfection of HeLa cells with siR-
PA1 duplexes apparently caused Chk2 (Thr68) phosphoryla-
tion even in the absence of VP-16 (Fig. 1). Interestingly, ATM
(Ser1981) phosphorylation, which is used to evaluate ATM
activation [24], occurred concomitantly with Chk2 (Thr68)
phosphorylation in HeLa cells treated with VP-16 or transfec-
ted with siRPA1 (Fig. 1A). Moreover, reduction of Rad9 did
not signiﬁcantly alter siRPA1-induced Chk2 phosphorylation
(Fig. 1B and C). These results, which were conﬁrmed in two
additional cell lines, HCT116 and 293 (not shown), suggest
that loss of RPA1 spontaneously activates Chk2.
3.2. Chk2 phosphorylation induced by siRPA1 can be
blocked by caﬀeine
We next attempted to identify the kinase(s) involved in Chk2
(Thr68) phosphorylation induced by siRPA1 transfection. To
this end, a panel of kinase inhibitors, including caﬀeine, wort-
mannin, LY294002, ﬂavopiridol, SB203580, SP600125, stauro-
sporine and PD98059, was examined for their ability to inhibit
RPA1 knockdown-induced Chk2 phosphorylation (data not
shown). Among these agents, caﬀeine, wortmannin and
LY294002 showed inhibition of Chk2 (Thr68) phosphoryla-
tion in siRPA1 transfected HeLa cells (Fig. 2A–D). Quantita-
tive analysis indicated that the ATM/ATR inhibitor caﬀeine
could block siRPA1-induced Chk2 phosphorylation com-
pletely, while wortmannin (200 nM) and LY294002 (10 lM)eLa cells were transfected with siGFP, siRad9, siRPA1, or siRad9 plus
e ﬁrst transfection, cells were treated with (+) 12.5 lg/ml of VP-16 or
g buﬀer and subjected to SDS–PAGE/immunoblot analysis with the
and normalized by a-tubulin, and the levels of phospho-Thr68-Chk2
in the bar graph (C).
Fig. 2. Caﬀeine blocks Chk2 (Thr68) phosphorylation and p21 expression induced by siRPA1. (A) HeLa cells were transfected with siGFP or
siRPA1 duplexes three times over a 3-day period. Seventy-two hours after the ﬁrst transfection, cells were treated with (+) 5 mM caﬀeine or 200 nM
wortmannin for 24 h, or mock treated. Cell lysates were prepared with SDS-sampling buﬀer and analyzed by SDS–PAGE/immunoblotting with
antibodies speciﬁc for phospho-Thr68-Chk2, RPA1 and a-tubulin. (C) HeLa cells were transfected with siRNAs as described in (A), treated with (+)
5 mM of caﬀeine or 10 lM LY294002 for 24 h or mock treated, and subjected to cell lysate preparation and SDS–PAGE/immunoblot analysis with
the indicated antibodies. The results of immunoblotting were quantitated and normalized by a-tubulin, and the levels of phospho-Thr68-Chk2 and
p21 relative to those of untreated siGFP cells, which were set as 1.0, are shown in the bar graphs (B, D and E).
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wortmannin and LY294002 are PI3 kinase inhibitors but also
inhibit other PI3K-related kinases such as ATM, ATR and
DNA-PK at higher concentrations [25,26], these results sug-
gest that ATM and/or ATR may contribute to Chk2 phos-
phorylation induced by RPA1 knockdown. Indeed, ATM
was activated by siRPA1 transfection (Fig. 1A). However,
reduction of RPA1 did not signiﬁcantly induce Chk1
(Ser345) phosphorylation (Fig. 1A), implying that siRPA1
treatment may not have an eﬀect on the ATR pathway.
Moreover, as shown in Fig. 2C and E, the levels of p21 pro-
tein, one of the downstream targets of Chk2, increased in siR-
PA1-transfected HeLa cells concomitantly with Chk2 (Thr68)
phosphorylation. This siRPA1-induced p21 expression was
blocked completely by 5 mM caﬀeine or partially by 10 lM
LY294002 treatment (Fig. 2C and E). It was previously shown
that caﬀeine treatment reduces the expression of p21 in both
irradiated and non-irradiated cells [27]. Similarly, the basal lev-
els of Chk2 (Thr68) phosphorylation and p21 expression weredecreased in the control siGFP cells treated with caﬀeine (Fig.
2). In general, a correlation between higher levels of Chk2
(Thr68) phosphorylation and higher protein expression of
p21 was observed in HeLa cells transfected with siRNAs and
treated with or without kinase inhibitors (Fig. 2 and data
not shown). Consistently, suppression of RPA1 resulted in a
slowing of S phase progression and G2/M cell-cycle arrest of
HeLa cells ([28] and data not shown). Notably, HeLa cells lack
functional p53, the principal mediator of p21 expression in re-
sponse to DNA damage, suggesting that siRPA1 upregulates
the p21 protein levels and induces cell-cycle arrest through a
p53-independent pathway.
3.3. ATM is the major kinase responsible for siRPA1-induced
Chk2 (Thr68) phosphorylation
It is well accepted that Chk2, a stable protein present
throughout the cell cycle, is activated mainly by ATM in re-
sponse to DNA damage [29]. To conﬁrm that ATM is the ki-
nase that phosphorylates Chk2 at Thr68 in siRPA1-transfected
Fig. 3. Knockdown of ATM inhibits siRPA1 induction of Chk2 (Thr68) phosphorylation. (A) HeLa cells were transfected with siGFP or siRPA1
three times at 24-h intervals. In the case of siATM transfection, cells were transfected twice by mock or RPA1 siRNA, and at the third transfection
ATM siRNA SMARTpool duplexes were included according to the manufacturers method. Cell lysates were prepared 24 h later and subjected to
SDS–PAGE/immunoblot analysis with antibodies speciﬁc for phospho-Thr68-Chk2, RPA1, ATM, or a-tubulin. (B) The immunoblot results were
quantitated and normalized by a-tubulin, and the levels of phospho-Thr68-Chk2 relative to those of siGFP-transfected cells, which were set as 1.0,
are shown in the bar graph.
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(siATM) to reduce ATM expression and checked the status
of Thr68 phosphorylation in HeLa cells. As expected, levels
of Chk2 (Thr68) phosphorylation decreased apparently in
HeLa cells cotransfected with siRPA1 and siATM, compared
to those of siRPA1-transfected HeLa cells (Fig. 3). These re-
sults strongly suggest that ATM is the major kinase responsi-
ble for Chk2 (Thr68) phosphorylation induced by the loss of
RPA1 protein expression.
Taken together, the results presented above indicate that
knockdown of the RPA1 protein results in Chk2 activation
through a caﬀeine-sensitive ATM-dependent pathway. How
does loss of RPA1 activate ATM? One possibility is that
RPA has an inhibitory function on ATM. It was recently re-
ported that ATM forms a homodimer that inactivates this ki-
nase in cells under normal conditions, and DNA damage
induces a structural change of chromatin that leads to auto-
phosphorylation of ATM [24]. Once phosphorylated at
Ser1981, ATM becomes activated, which in turn phosphory-
lates Chk2. Therefore, it is possible that knockdown of
RPA1, which normally binds to and stabilizes ssDNA during
DNA replication, repair and recombination, causes structural
changes in chromatin that induce ATM phosphorylation/acti-
vation. Moreover, ATM has been shown to interact with and
phosphorylate RPA [15]. Therefore, it is also possible that loss
of RPA frees ATM to phosphorylate Chk2.
In addition, RPA has been shown to bind DNA-PK at rep-
licating DNA sites in untreated cells, and DNA damage in-
duces activation of DNA-PK that in turn phosphorylates
RPA [14]. The phosphorylated RPA then dissociates from
the DNA-PK complex, allowing it to phosphorylate down-
stream targets. Therefore, it is not diﬃcult to imagine that
knockdown of RPA may induce DNA-PK activation that also
contributes to siRPA1-induced Chk2 (Thr68) phosphoryla-
tion. However, our results that Thr68 phosphorylation in siR-
PA1 transfectants can be completely blocked by caﬀeine,
which inhibits ATM and ATR but not DNA-PK, argue that
DNA-PK is probably not involved in Chk2 phosphorylation
induced by siRPA1.Due to the functional importance of RPA in DNA metabo-
lism, loss of RPA would interfere with DNA replication,
resulting in activation of DNA integrity checkpoints and inhi-
bition of cell-cycle progression. Our results did indeed show
that knockdown of RPA1 could induce p21 expression con-
comitant with Chk2 (Thr68) phosphorylation. In support of
this notion, reduction of RPA1 reportedly suppresses cell-cycle
progression through S and G2/M phases [28]. Collectively,
these ﬁndings suggest that knockdown of RPA1 can activate
the ATM/Chk2 signaling pathway and induce cell cycle arrest
in the absence of external DNA-damaging agents.
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